NEWS
DEXCOM PARTNERS WITH TANDEM
T2 STUDY REQUEST FOR PARTICIPANTS
Dexcom Partners with Tandem Diabetes
Care on the t:slim X2 insulin pump in the
UK, Sweden, Italy and Spain. Dexcom's
CGM system, combined with Tandem's
Basal-IQ technology, predicts and
prevents hypos while at the same time
having no requirement for 'fingerstick'
calibrations.
Tandem's t:slim X2 insulin pump with
Basal-IQ technology uses Dexcom G6
CGM readings to predict glucose levels
30 minutes ahead and suspend insulin
delivery when glucose is predicted to go
low. Insulin delivery resumes as soon as
sensor glucose values begin to rise. Use
of the integrated system reduced the
time spent below 3.9mmol/L (70 mg/
dL) by 31% compared to use of a CGMintegrated pump without automated
insulin suspension.
Furthermore, with the Dexcom G6
app, users can share their glucose
information with up to five people.
Whether you are a parent of a child with
diabetes or an adult, the Dexcom G6 lets
you seamlessly keep track of glucose
levels and enables the user's care team to
remotely monitor their loved ones for extra
peace of mind.
www.dexcom.com
www.airliquidehealthcare.co.uk/diabetes-service
You are invited to take part in a research
study, Evaluating a Diabetes Specific
Online CBT Intervention
Ieso Digital Health IS running a
study to evaluate an online, diabetes
specific, cognitive behavioural therapy
(CBT) intervention for people with Type 2
diabetes.
You are free to decide whether or not
to take part in this study and if you decide
to participate you may change your mind
at any time.
Overview: There is a strong evidence
base that supports the effectiveness of
cognitive behavioural therapy (CBT) for
patients with a diagnosis of diabetes
(type 1 and type 2) who also suffer from
a common mental health disorder such
as anxiety or depression. Both anxiety
and depression can have a significant
impact on an individual's ability to manage
their diabetes and therefore successful
treatment of these common mental health
conditions can positively affect a person's
physical and mental health.
CBT is traditionally delivered face-toface but currently
there are not enough
therapists to provide treatment for all
the people who would
benefit from it. One
method of delivering
CBT via an online
therapist. Around
20,000 NHS patients
have already had
CBT using this online
method and we know
that people are just as
likely to get better using
online CBT as they
are using face-to face
methods. This study
will help us understand
whether online methods
of delivering CBT help
people who have Type 2 diabetes and
anxiety or depression.
Anyone, over the age of 18 who has
type 2 diabetes, for 12 months or more,
and has also experienced any symptoms
of low mood or anxiety is invited to
participate in this study.
Register your interest by following the link:
registration.iesohealth/cbt4diabetes Can CBT help with T2D?
Take part in a study to find
out!